Insider Trading activities of Allergan Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allergan Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allergan Inc since year 2005. Table 2 shows the detailed insider transactions of Allergan Inc since 2005. The reporting company's ticker symbol is AGN. The reporting company's CIK number is 850693.
The total value of stock buying since 2005 is $2,481,409.
The total value of stock sales since 2005 is $571,398,347.
The total value of stock option exercises since 2005 is $239,864,833.


Go to page:  1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Allergan Inc (AGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-03 0 $0 0 $0 17,575 $0
2015-02 0 $0 0 $0 2,382 $0
2014-04 0 $0 14,500 $2,259,325 14,500 $1,084,480
2014-02 0 $0 622,975 $76,400,500 613,375 $30,132,684
2014-01 0 $0 84,000 $9,727,200 84,000 $4,701,900
2013-12 0 $0 151,500 $16,550,662 151,500 $3,799,312
2013-11 0 $0 3,000 $292,383 0 $0
2013-10 0 $0 2,000 $180,280 1,000 $51,715
2013-09 0 $0 2,000 $179,560 1,000 $51,715
2013-08 0 $0 2,000 $179,780 1,000 $51,715
2013-07 0 $0 2,000 $182,300 1,000 $51,715
2013-06 0 $0 2,000 $202,500 1,000 $36,490
2013-05 0 $0 86,000 $8,900,303 103,225 $4,898,190
2013-04 0 $0 35,200 $4,023,104 38,482 $1,301,499
2013-03 0 $0 25,300 $2,815,560 24,300 $1,042,258
2013-02 0 $0 2,000 $215,640 1,000 $60,600
2013-01 0 $0 31,700 $3,118,610 30,700 $1,395,780
2012-12 0 $0 6,800 $620,391 6,800 $204,850
2012-11 0 $0 317,560 $29,092,758 273,960 $15,122,188
2012-10 0 $0 629,800 $59,020,667 631,000 $24,767,116
2012-09 0 $0 3,500 $319,800 2,000 $121,200
2012-08 0 $0 164,300 $14,085,415 147,800 $5,917,491
2012-07 0 $0 1,500 $127,050 0 $0
2012-06 0 $0 2,500 $225,077 1,000 $60,600
2012-05 0 $0 132,462 $12,332,308 131,500 $5,322,826
2012-04 0 $0 2,500 $237,825 1,000 $36,490
2012-03 0 $0 35,207 $3,289,548 29,100 $1,686,268
2012-02 0 $0 66,000 $5,700,750 66,000 $2,721,840
2011-12 0 $0 566,754 $48,753,374 566,754 $18,359,429
2011-10 0 $0 38,200 $3,222,299 33,200 $1,284,674
2011-09 0 $0 222 $18,206 0 $0
2011-05 0 $0 164,990 $13,377,823 111,100 $5,066,653
2011-04 0 $0 25,351 $1,961,706 0 $0
2011-03 4,250 $303,875 0 $0 0 $0
2011-02 0 $0 95,226 $7,030,588 65,450 $2,805,842
2011-01 0 $0 1,000 $72,090 0 $0
2010-12 0 $0 59,449 $4,138,068 22,420 $898,794
2010-11 0 $0 1,040,576 $75,775,206 1,181,870 $40,996,672
2010-10 0 $0 20,000 $1,440,000 0 $0
2010-09 0 $0 35,721 $2,361,908 35,721 $1,841,846
2010-07 0 $0 43,596 $2,819,789 43,596 $1,412,248
2010-05 0 $0 15,598 $976,416 25,598 $992,156
2010-03 0 $0 7,212 $470,251 7,212 $233,625
2010-02 0 $0 8,200 $484,256 0 $0
2009-12 0 $0 18,000 $1,127,600 8,000 $259,152
2009-11 0 $0 117,932 $6,815,277 112,932 $3,238,355
2009-09 0 $0 15,000 $866,000 5,000 $161,970
2009-08 0 $0 22,050 $1,227,354 12,050 $466,274
2009-07 0 $0 2,000 $106,700 2,000 $64,788
2009-02 0 $0 2,500 $104,650 0 $0
2008-12 0 $0 13,936 $561,188 22,420 $374,257
2008-11 30,300 $1,153,446 0 $0 0 $0
2008-10 10,000 $395,070 0 $0 0 $0
2008-08 0 $0 3,000 $168,375 0 $0
2008-07 0 $0 5,000 $260,250 5,000 $83,450
2008-05 12,000 $629,018 0 $0 0 $0
2008-02 0 $0 5,000 $323,610 5,000 $83,450
2007-12 0 $0 449,666 $30,356,153 449,666 $11,749,772
2007-11 0 $0 50,292 $3,259,892 50,292 $1,010,629
2007-08 0 $0 579,866 $37,378,236 569,866 $11,089,185
2007-07 0 $0 20,154 $1,159,898 20,154 $1,071,291
2007-06 0 $0 46,562 $3,162,768 46,562 $2,750,628
2007-05 0 $0 15,704 $1,953,520 10,704 $932,496
2007-02 0 $0 5,248 $601,188 5,248 $175,230
2006-11 0 $0 188,276 $22,584,030 178,276 $13,995,754
2006-08 0 $0 221,677 $24,486,937 150,274 $3,223,458
2006-07 0 $0 11,250 $1,215,000 11,250 $650,700
2006-06 0 $0 5,000 $525,000 5,000 $261,300
2006-04 0 $0 24,650 $2,662,320 24,600 $1,424,519
2006-03 0 $0 159,495 $17,311,125 155,795 $8,285,314

Table 2. Detailed insider stock purchases, sales, and option exercises of Allergan Inc insiders (AGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-03-17 Proctor Timothy D (Director) Option Ex 1,189 .00 0
2015-03-17 Dunsire Deborah (Director) Option Ex 8,859 .00 0
2015-03-17 Jones Trevor M (Director) Option Ex 7,527 .00 0
2015-02-20 Gangolli Julian S (CVP & Pres, North America) Option Ex 514 .00 0
2015-02-20 Diradoorian Raymond H (EVPGlobal Technical Operations) Option Ex 277 .00 0
2015-02-20 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 212 .00 0
2015-02-20 Pyott David E I (Chairman of the Board and CEO) Option Ex 1,379 .00 0
2014-04-22 Sherman Scott D (Executive Vice President, HR) Sale 10,000 163.00 1,630,000
2014-04-22 Sherman Scott D (Executive Vice President, HR) Option Ex 10,000 75.58 755,800
2014-04-21 Sherman Scott D (Executive Vice President, HR) Sale 4,500 139.85 629,325
2014-04-21 Sherman Scott D (Executive Vice President, HR) Option Ex 4,500 73.04 328,680
2014-02-21 Lavigne Louis J Jr (Director) Sale 5,400 125.79 679,244
2014-02-21 Ingram Douglas S (President) Sale 0 125.70 0
2014-02-19 Diradoorian Raymond H (EVPGlobal Technical Operations) Sale 23,000 126.66 2,913,111
2014-02-19 Diradoorian Raymond H (EVPGlobal Technical Operations) Option Ex 23,000 58.55 1,346,650
2014-02-19 Hudson Dawn E (Director) Sale 4,200 126.35 530,682
2014-02-19 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 38,900 126.39 4,916,493
2014-02-19 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Option Ex 38,900 40.16 1,562,223
2014-02-18 Sherman Scott D (Executive Vice President, HR) Sale 5,000 125.74 628,700
2014-02-18 Sherman Scott D (Executive Vice President, HR) Option Ex 5,000 75.58 377,900
2014-02-14 Sherman Scott D (Executive Vice President, HR) Sale 0 124.76 0
2014-02-14 Ingram Douglas S (President) Sale 84,000 124.40 10,449,432
2014-02-14 Ingram Douglas S (President) Option Ex 84,000 55.98 4,701,900
2014-02-12 Barlow James F (SR. VP, Corp. Controller (PAO)) Sale 23,875 123.52 2,949,159
2014-02-12 Barlow James F (SR. VP, Corp. Controller (PAO)) Option Ex 23,875 65.70 1,568,468
2014-02-12 Pyott David E I (Chairman of the Board and CEO) Sale 252,000 123.12 31,025,484
2014-02-12 Pyott David E I (Chairman of the Board and CEO) Option Ex 252,000 36.15 9,109,800
2014-02-11 Diradoorian Raymond H (EVPGlobal Technical Operations) Sale 17,000 121.82 2,070,957
2014-02-11 Diradoorian Raymond H (EVPGlobal Technical Operations) Option Ex 17,000 55.98 951,575
2014-02-11 Lavigne Louis J Jr (Director) Sale 54,600 122.39 6,682,712
2014-02-11 Lavigne Louis J Jr (Director) Option Ex 54,600 55.06 3,006,003
2014-02-10 Sherman Scott D (Executive Vice President, HR) Sale 5,000 120.00 600,000
2014-02-10 Sherman Scott D (Executive Vice President, HR) Option Ex 5,000 75.58 377,900
2014-02-07 Sherman Scott D (Executive Vice President, HR) Sale 4,500 118.55 533,484
2014-02-07 Sherman Scott D (Executive Vice President, HR) Option Ex 4,500 73.04 328,680
2014-02-07 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 105,500 117.74 12,421,042
2014-02-07 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Option Ex 105,500 64.47 6,801,585
2014-01-14 Whitcup Scott M (Executive VP, R&D, CSO) Sale 42,000 117.80 4,947,600
2014-01-14 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 42,000 55.98 2,350,950
2014-01-08 Whitcup Scott M (Executive VP, R&D, CSO) Sale 42,000 113.80 4,779,600
2014-01-08 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 42,000 55.98 2,350,950
2013-12-27 Gangolli Julian S (CVP & Pres, North America) Sale 52,500 110.08 5,779,462
2013-12-27 Gangolli Julian S (CVP & Pres, North America) Option Ex 52,500 49.64 2,606,362
2013-12-20 Whitcup Scott M (Executive VP, R&D, CSO) Sale 66,000 108.80 7,180,800
2013-12-20 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 66,000 18.08 1,192,950
2013-11-27 Hudson Dawn E (Director) Sale 3,000 97.46 292,383
2013-10-15 Jones Trevor M (Director) Sale 2,000 90.14 180,280
2013-10-15 Jones Trevor M (Director) Option Ex 1,000 51.72 51,715
2013-09-16 Jones Trevor M (Director) Sale 2,000 89.78 179,560
2013-09-16 Jones Trevor M (Director) Option Ex 1,000 51.72 51,715
2013-08-15 Jones Trevor M (Director) Sale 2,000 89.89 179,780
2013-08-15 Jones Trevor M (Director) Option Ex 1,000 51.72 51,715
2013-07-15 Jones Trevor M (Director) Sale 2,000 91.15 182,300
2013-07-15 Jones Trevor M (Director) Option Ex 1,000 51.72 51,715
2013-06-17 Jones Trevor M (Director) Sale 2,000 101.25 202,500
2013-06-17 Jones Trevor M (Director) Option Ex 1,000 36.49 36,490
2013-05-15 Jones Trevor M (Director) Sale 2,000 103.40 206,800
2013-05-15 Jones Trevor M (Director) Option Ex 1,000 36.49 36,490
2013-05-09 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 40,100 103.72 4,159,292
2013-05-09 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Option Ex 40,100 58.55 2,347,855
2013-05-08 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 43,900 103.28 4,534,211
2013-05-08 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Option Ex 43,900 57.26 2,513,845
2013-05-01 Boyer Herbert W Ph D (Director) Option Ex 18,225 .00 0
2013-04-29 Ryan Stephen J (Director) Option Ex 4,282 .00 0
2013-04-15 Jones Trevor M (Director) Sale 2,000 115.74 231,480
2013-04-15 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2013-04-11 Whitcup Scott M (Executive VP, R&D, CSO) Sale 12,005 115.00 1,380,575
2013-04-11 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 12,005 36.15 433,980
2013-04-03 Whitcup Scott M (Executive VP, R&D, CSO) Sale 13,195 115.00 1,517,425
2013-04-03 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 13,195 36.15 476,999
2013-04-01 Whitcup Scott M (Executive VP, R&D, CSO) Sale 8,000 111.70 893,624
2013-04-01 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 8,000 41.24 329,920
2013-03-26 Whitcup Scott M (Executive VP, R&D, CSO) Sale 11,484 112.00 1,286,208
2013-03-26 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 11,484 36.15 415,146
2013-03-25 Whitcup Scott M (Executive VP, R&D, CSO) Sale 4,925 112.00 551,600
2013-03-25 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 4,925 36.15 178,038
2013-03-21 Whitcup Scott M (Executive VP, R&D, CSO) Sale 1,191 112.00 133,392
2013-03-21 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 1,191 36.15 43,054
2013-03-15 Jones Trevor M (Director) Sale 2,000 108.68 217,360
2013-03-15 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2013-03-05 Ryan Stephen J (Director) Sale 5,700 110.00 627,000
2013-03-05 Ryan Stephen J (Director) Option Ex 5,700 60.60 345,420
2013-02-15 Jones Trevor M (Director) Sale 2,000 107.82 215,640
2013-02-15 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2013-01-15 Jones Trevor M (Director) Sale 2,000 103.30 206,600
2013-01-15 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2013-01-15 Ryan Stephen J (Director) Sale 5,700 103.30 588,810
2013-01-15 Ryan Stephen J (Director) Option Ex 5,700 60.60 345,420
2013-01-04 Whitcup Scott M (Executive VP, R&D, CSO) Sale 24,000 96.80 2,323,200
2013-01-04 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 24,000 41.24 989,760
2012-12-07 Whitcup Scott M (Executive VP, R&D, CSO) Sale 6,800 91.23 620,391
2012-12-07 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 6,800 30.12 204,850
2012-11-29 Endicott David J. (CVP and President, AGN Med) Sale 52,560 92.43 4,857,963
2012-11-29 Endicott David J. (CVP and President, AGN Med) Option Ex 52,560 64.47 3,388,543
2012-11-28 Gangolli Julian S (CVP & Pres, North America) Sale 55,378 91.66 5,075,947
2012-11-28 Gangolli Julian S (CVP & Pres, North America) Option Ex 55,378 58.55 3,242,381
2012-11-28 Gallagher Michael R (Director) Sale 13,366 91.48 1,222,761
2012-11-28 Gallagher Michael R (Director) Option Ex 9,768 49.19 480,468
2012-11-27 Gangolli Julian S (CVP & Pres, North America) Sale 34,622 92.25 3,193,983
2012-11-27 Gangolli Julian S (CVP & Pres, North America) Option Ex 34,622 49.36 1,708,768
2012-11-27 Gallagher Michael R (Director) Sale 32,434 92.00 2,983,928
2012-11-27 Gallagher Michael R (Director) Option Ex 20,632 43.01 887,423
2012-11-26 Jones Trevor M (Director) Sale 2,500 91.30 228,250
2012-11-26 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-11-26 Gallagher Michael R (Director) Sale 4,700 91.20 428,658
2012-11-21 Ray Russell T (Director) Sale 33,000 91.05 3,004,584
2012-11-21 Ray Russell T (Director) Option Ex 15,000 39.74 596,130
2012-11-21 Hudson Dawn E (Director) Sale 5,000 91.00 455,000
2012-11-20 Diradoorian Raymond H (EVPGlobal Technical Operations) Sale 25,000 91.02 2,275,575
2012-11-20 Diradoorian Raymond H (EVPGlobal Technical Operations) Option Ex 25,000 55.98 1,399,375
2012-11-20 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 59,000 90.95 5,366,109
2012-11-20 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Option Ex 60,000 55.98 3,358,500
2012-10-26 Jones Trevor M (Director) Sale 2,500 91.30 228,250
2012-10-26 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-10-17 Whitcup Scott M (Executive VP, R&D, CSO) Sale 5,000 94.70 473,500
2012-10-17 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 5,000 30.12 150,625
2012-10-05 Pyott David E I (Chairman, President and CEO) Sale 307,956 93.72 28,862,868
2012-10-05 Pyott David E I (Chairman, President and CEO) Option Ex 307,956 41.24 12,700,105
2012-10-04 Pyott David E I (Chairman, President and CEO) Sale 308,344 93.73 28,899,849
2012-10-04 Pyott David E I (Chairman, President and CEO) Option Ex 311,044 37.54 11,675,036
2012-10-01 Whitcup Scott M (Executive VP, R&D, CSO) Sale 6,000 92.70 556,200
2012-10-01 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 6,000 30.12 180,750
2012-09-26 Jones Trevor M (Director) Sale 2,500 91.92 229,800
2012-09-26 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-09-12 Jones Trevor M (Director) Sale 1,000 90.00 90,000
2012-09-12 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-08-30 Ingram Douglas S (EVP and President, EAME) Sale 100,000 85.78 8,578,200
2012-08-30 Ingram Douglas S (EVP and President, EAME) Option Ex 100,000 36.15 3,615,000
2012-08-29 Lavigne Louis J Jr (Director) Sale 15,000 85.04 1,275,600
2012-08-27 Jones Trevor M (Director) Sale 1,500 85.43 128,145
2012-08-07 Ryan Stephen J (Director) Sale 15,900 85.34 1,356,985
2012-08-07 Ryan Stephen J (Director) Option Ex 15,900 50.49 802,791
2012-08-06 Ryan Stephen J (Director) Sale 15,900 85.47 1,358,925
2012-08-06 Ryan Stephen J (Director) Option Ex 15,900 53.02 842,970
2012-08-03 Ryan Stephen J (Director) Sale 15,000 86.50 1,297,560
2012-08-03 Ryan Stephen J (Director) Option Ex 15,000 39.74 596,130
2012-08-01 Jones Trevor M (Director) Sale 1,000 90.00 90,000
2012-08-01 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-07-26 Jones Trevor M (Director) Sale 1,500 84.70 127,050
2012-06-26 Jones Trevor M (Director) Sale 2,500 90.03 225,077
2012-06-26 Jones Trevor M (Director) Option Ex 1,000 60.60 60,600
2012-05-30 Whitcup Scott M (Executive VP, R&D, CSO) Sale 1,500 90.71 136,062
2012-05-30 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 1,500 30.12 45,187
2012-05-29 Jones Trevor M (Director) Sale 2,500 91.14 227,837
2012-05-29 Jones Trevor M (Director) Option Ex 1,000 51.72 51,715
2012-05-16 Whitcup Scott M (Executive VP, R&D, CSO) Sale 1,500 92.00 138,000
2012-05-16 Whitcup Scott M (Executive VP, R&D, CSO) Option Ex 1,500 30.12 45,187
2012-05-07 Endicott David J. (CVP and President, AGN Med) Sale 27,500 93.81 2,579,747
2012-05-07 Endicott David J. (CVP and President, AGN Med) Option Ex 27,500 49.64 1,365,237
2012-05-04 Edwards Jeffrey L (EVP, Fin & Bus. Dev., CFO) Sale 99,462 93.01 9,250,662
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allergan Inc (symbol AGN, CIK number 850693) see the Securities and Exchange Commission (SEC) website.